Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Licensing opportunity announced: liposomal compound for treatment of ARDS

Jan. 19, 1999

New mediator of allergic asthma revealed in studies using interleukin-13 fusion protein

Jan. 19, 1999

Research at Jouveinal leads to potent and selective PDE4 inhibitors

Jan. 18, 1999

Teijin in-licenses novel asthma therapeutic from Byk Gulden

Jan. 18, 1999

Tianeptine, a 5-HT uptake enhancer, demonstrates excellent efficacy in asthma

Jan. 15, 1999

Seretide cleared for marketing in most E.U. countries

Jan. 15, 1999

Novel condensed pyridazines claimed by Takeda for allergic conditions

Jan. 13, 1999

Two major clinical trials support safety and efficacy of TOBI in cystic fibrosis patients

Jan. 11, 1999

Magainin and Genentech enter collaboration for asthma treatment

Jan. 11, 1999

New LTB4 receptor antagonists disclosed by Boehringer Ingelheim

Dec. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...